[Federal Register Volume 79, Number 144 (Monday, July 28, 2014)]
[Notices]
[Page 43782]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-17681]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Fresenius Kabi 
USA, LLC

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Fresenius Kabi USA, LLC applied to be registered as an 
importer of a basic class of narcotic controlled substance. The Drug 
Enforcement Administration grants Fresenius Kabi USA, LLC registration 
as an importer of this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated December 31, 2013, and 
published in the Federal Register on January 10, 2014, 79 FR 1888, 
Fresenius Kabi USA, LLC, 3159 Staley Road, Grand Island, New York 
14072, applied to be registered as an importer of a certain basic class 
of controlled substance. No comments or objections were submitted for 
this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of Fresenius Kabi USA, LLC to import the basic class of 
controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of remifentanil (9739), a basic class of 
narcotic controlled substance listed in schedule II.
    The company plans to import remifentanil for product development 
and preparation of stability batches.

    Dated: July 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-17681 Filed 7-25-14; 8:45 am]
BILLING CODE 4410-09-P